BMRN Financial Facts
NET INCOME (LOSS) PER SHARE, BASIC: -0.26Weighted average common shares outstanding, basic: 167.71M
See Full Income Statement
Intangible assets, net: 561.39M
Accumulated other comprehensive income (loss): 2.16M
See Full Balance Sheet
BioMarin Pharmaceutical Inc. (BMRN) Earnings
|
Expand Research on BMRN
Next EPS Date | 4/24/24 | EPS Growth Rate | -46.7% |
---|---|---|---|
Average EPS % Beat Rate | +141.4% | Revenue Growth Rate | +8.9% |
Average % Move 1-Wk after EPS | -0.4% | Normal Earnings Time | After Close |
Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
---|---|---|---|---|---|---|---|---|---|---|---|
10/28/10 | Q310 | $0.06 | -$0.01 | +$0.07 | N/A | N/A | N/A | Details | |||
2/17/11 | Q410 | $0.10 | -$0.02 | +$0.12 | $101.61M | $105.14M | Details | ||||
2/25/16 | Q415 | $0.39 | $0.99 | -$0.60 | $227.9M | $224.38M | Details | ||||
10/27/21 | Q321 | -$0.20 | -$0.24 | +$0.04 | $408.7M | $435.89M | = | Details | |||
10/23/14 | Q314 | -$0.16 | -$0.22 | +$0.06 | $176.8M | $206M | N/A | Details | |||
8/3/22 | Q222 | $0.15 | $0.03 | +$0.12 | $533.8M | $520.35M | = | Details | |||
2/21/13 | Q412 | -$0.43 | -$0.27 | -$0.16 | $130.96M | $129.7M | = | Details | |||
7/30/14 | Q214 | -$0.23 | -$0.41 | +$0.18 | $191.8M | $159.7M | N/A | Details |